The University of Kansas Alzheimer's Disease Center in Fairway recently partnered with the Global Alzheimer's Platform Foundation to expedite clinical trials for possible Alzheimer's cures, according to the Kansas City Business Journal.
The GAP Foundation was created to aid researchers in being more effective in Alzheimer's clinical trials, which can often be complicated by high costs and significant amount of time necessary to conduct such trials.
The foundation hopes to accelerate trials by improving enrollment through a highly efficient approach to identify, evaluate and enroll appropriate trial candidates. The foundation also works to put together patient safety standards and drug company contracts.
The KU Alzheimer's Disease Center is currently home to 24 active Alzheimer's studies both searching for new preventive techniques and a cure. Over the next three years, researchers hope to enroll 700 clinical trial volunteers.
"We're going after a number of targets," Jeffery Burns, MD, co-director of the center, told the Journal. "We just need more wins."
More articles on quality:
Patient Safety Movement calls on Congress to reject ACA repeal without replacement
EHR use improves safety, communication on blood thinner use during care transitions
Diagnostic variability, error rates high in lumbar spine MRI examinations